U.K. proffers €56M for 12 new research units

A dozen new Biomedical Research Units created under the U.K.'s National Institute for Health Research will receive more than €56 million to fund translational work on ailments that include obesity and heart disease. Each of the BRUs match a university with the National Health Service (NHS) Trust. And the public funding is intended to finance work in research areas that are usually starved of funding. Their work is also intended to complement R&D programs at the 12 existing NIHR Biomedical Research Centres.

"Together, these are among the most outstanding centres of medical research in the world," said the Department of Health.

- read the story in PharmaTimes 

Related Articles:
Biopharma execs sign on to tout UK's R&D work. U.K. report
Market volatility spurs M&A talks at UK biotechs. M&A report
U.K. to require more disclosure of drug trial data. Drug trial report
U.K. researchers driven out by tough regulations. U.K. report
GSK looks abroad for more scientists as U.K. shortage grows. Report

Suggested Articles

Removing the IRE1-alpha gene from beta cells in mouse models of Type 1 diabetes restored normal insulin production, scientists found.

Selectively targeting TGF-beta1 with Scholar Rock's SRK-181 overcame primary resistance to checkpoint inhibitor therapy in mice.

Enhertu produced a 55.6% objective response rate in HER2-positive non-small cell lung cancer patients in a phase 1 trial.